ID: ALA3888551
Type: Binding
Description: Enzyme Inhibition Assay : Plasmepsin-2 (PM-2; Plm II) and Plasmepsin (PM-4; Plm IV) expression and purification was performed following the published protocols (Istvan E S and Goldberg D E, 2005). The final purified protein was activated by diluting the protein to 0.3 mg/mL in activating buffer (0.1 M citrate pH 4.5, 0.1% Tween-20, 50 mM dithiothreitol) and incubated at room temperature for 40 min, then the activated enzyme was diluted in assay buffer (50 mM sodium acetate pH 4.7, 0.01% Tween-20). The enzymatic inhibition reaction was performed in 384 well plates with a total volume of 20 μl. 10 μl of diluted PM-2 or PM-4 enzyme was added to the 384-well plate except blank wells (blank wells add 10 μL of assay buffer) and 20 nL of serials of diluted 1000× compounds were added to the wells with 520 Echo® Liquid Handling System (Labcyte Inc.). 10 μL PM-2 peptide substrate (AnaSpec, Cat#, 62050) with assay buffer was then added to final concentration of 20 μM to start the reaction.
Bioactivity
Activity Types for Assay ALA3888551
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
383.50 | 4.49 | 4.49 |
394.47 | 3.83 | 3.83 |
440.55 | 4.70 | 4.70 |
410.52 | 4.69 | 4.69 |
393.49 | 3.65 | 3.65 |
395.46 | 2.49 | 2.49 |
394.48 | 2.07 | 2.07 |
408.50 | 2.41 | 2.41 |
494.59 | 3.71 | 3.71 |
409.49 | 2.74 | 2.74 |
393.49 | 3.65 | 3.65 |